Back
Ascendis Pharma AS Stock Price Chart
Sponsored
ASND
Sponsored
Invest in the Next Big AI Disruptor Today
Learn More
Sell
38
ASND
Ascendis Pharma AS
Last Price:
140.94
Seasonality Move:
7.62%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bearish and ASND is experiencing slight selling pressure.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 146.49 | Sell |
20-day SMA: | 136.38 | Buy |
50-day SMA: | 135.04 | Buy |
200-day SMA: | 137.28 | Buy |
8-day EMA: | 145.87 | Buy |
20-day EMA: | 141.21 | Buy |
50-day EMA: | 137.07 | Buy |
200-day EMA: | 131.18 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.39 | Buy |
Relative Strength Index (14 RSI): | 58.35 | Buy |
Chaikin Money Flow: | -47692 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (122.16 - 149.6) | Buy |
Bollinger Bands (100): | (125.22 - 142.02) | Buy |
Ascendis Pharma AS Technical Analysis
Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
- Ascendis Pharma AS share price is 146.29 while ASND 8-day simple moving average is 146.49, which is a Sell signal.
- The stock price of ASND is 146.29 while Ascendis Pharma AS 20-day SMA is 136.38, which makes it a Buy.
- Ascendis Pharma AS 50-day simple moving average is 135.04 while ASND share price is 146.29, making it a Buy technically.
- ASND stock price is 146.29 and Ascendis Pharma AS 200-day simple moving average is 137.28, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
38
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a Sell
The current Ascendis Pharma AS [ASND] share price is $146.29. The Score for ASND is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
8.74B
Price in USD:
146.29
Share Volume:
564.97K
Ascendis Pharma AS 52-Week Range
52-Week High:
161.00
52-Week Low:
85.29
Sell
38
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?
The Ascendis Pharma AS stock price is 146.29 USD today. -
Will ASND stock go up or go down?
Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators -
Is Ascendis Pharma AS overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
- Ascendis Pharma AS share price is 146.29 while ASND 8-day exponential moving average is 145.87, which is a Buy signal.
- The stock price of ASND is 146.29 while Ascendis Pharma AS 20-day EMA is 141.21, which makes it a Buy.
- Ascendis Pharma AS 50-day exponential moving average is 137.07 while ASND share price is 146.29, making it a Buy technically.
- ASND stock price is 146.29 and Ascendis Pharma AS 200-day simple moving average is 131.18, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
- Analysts estimate an earnings increase this quarter of $1.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.61 per share, and an increase next year of $4.43 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
- ASND Moving Average Covergence Divergence (MACD) indicator is 4.39, suggesting Ascendis Pharma AS is a Buy
- Ascendis Pharma AS Relative Strength Index (RSI) is 58.35, which suggest Ascendis Pharma AS is overbought
- The Bollinger Bands (25) for Ascendis Pharma AS is (122.16 - 149.6), which suggest Ascendis Pharma AS is a Buy
- The Bollinger Bands (100) for Ascendis Pharma AS is (125.22 - 142.02), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.